Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» FDA commissioner calls for Sarepta drug study to be retracted
FDA commissioner calls for Sarepta drug study to be retracted
FDA commissioner calls for Sarepta drug study to be retracted
Submitted by
admin
on September 22, 2016 - 12:18pm
Source:
Stat/Pharmalot
News Tags:
FDA
Sarepta Therapeutics
Robert Califf
Duchenne Muscular Dystrophy
eteplirsen
Headline:
FDA commissioner calls for Sarepta drug study to be retracted
Do Not Allow Advertisers to Use My Personal information
